Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Bacil Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:524516NSE Symbol: Not ListedP/E(TTM):44.87
ISIN Demat:INE711D01018Div & Yield %:0EPS(TTM):0.77
Book Value(Rs):17.985201Market Cap ( Cr.):49.59Face Value(Rs):10
    Change Company 
Date Headline
27-Sep-25 Bacil Pharma Ltd - Closure of Trading Window
15-Sep-25 Bacil Pharma to conduct AGM
03-Sep-25 Bacil Pharma announces board meeting date
27-Aug-25 Bacil Pharma Ltd - Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025
20-Aug-25 Bacil Pharma schedules board meeting
19-Aug-25 Bacil Pharma Ltd - Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Comp..
13-Aug-25 Bacil Pharma reports standalone net profit of Rs0.67 crore in the June 2025 quarter
11-Aug-25 Bacil Pharma to convene board meeting
18-Jul-25 Bacil Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jul-25 Bacil Pharma to conduct board meeting
<< < 1 2 3 > >>